159 related articles for article (PubMed ID: 38765704)
1. Effect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV Among HIV-Exposed Infants in Ethiopia: a Before-and-After Study.
Facha W; Tadesse T; Wolka E; Astatkie A
HIV AIDS (Auckl); 2024; 16():203-215. PubMed ID: 38765704
[TBL] [Abstract][Full Text] [Related]
2. Viral load non-suppression status among women exposed to Dolutegravir-based versus Efavirenz-based regimens in Ethiopia: A before-and-after study.
Facha W; Tadesse T; Wolka E; Astatkie A
PLoS One; 2024; 19(6):e0305331. PubMed ID: 38857273
[TBL] [Abstract][Full Text] [Related]
3. Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana.
Davey S; Ajibola G; Maswabi K; Sakoi M; Bennett K; Hughes MD; Isaacson A; Diseko M; Zash R; Batlang O; Moyo S; Lockman S; Lichterfeld M; Kuritzkes DR; Makhema J; Shapiro R
J Acquir Immune Defic Syndr; 2020 Jul; 84(3):235-241. PubMed ID: 32195745
[TBL] [Abstract][Full Text] [Related]
4. Magnitude and risk factors of mother-to-child transmission of HIV among HIV-exposed infants after Option B+ implementation in Ethiopia: a systematic review and meta-analysis.
Facha W; Tadesse T; Wolka E; Astatkie A
AIDS Res Ther; 2024 Jun; 21(1):39. PubMed ID: 38849895
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
7. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
[TBL] [Abstract][Full Text] [Related]
8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
9. National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia.
Agabu A; Baughman AL; Fischer-Walker C; de Klerk M; Mutenda N; Rusberg F; Diergaardt D; Pentikainen N; Sawadogo S; Agolory S; Dinh TH
PLoS One; 2020; 15(11):e0233341. PubMed ID: 33170840
[TBL] [Abstract][Full Text] [Related]
10. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Petlo C; Lockman S; Makhema J; Shapiro RL
JAMA Pediatr; 2017 Oct; 171(10):e172222. PubMed ID: 28783807
[TBL] [Abstract][Full Text] [Related]
11. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
[TBL] [Abstract][Full Text] [Related]
12. Impact of maternal ART on mother-to-child transmission (MTCT) of HIV at six weeks postpartum in Rwanda.
Mugwaneza P; Lyambabaje A; Umubyeyi A; Humuza J; Tsague L; Mwanyumba F; Mutabazi V; Nsanzimana S; Ribakare M; Irakoze A; Mutaganzwa E; Lombard C; Jackson D
BMC Public Health; 2018 Nov; 18(1):1248. PubMed ID: 30419870
[TBL] [Abstract][Full Text] [Related]
13. Exclusive breastfeeding among HIV exposed infants from birth to 14 weeks of life in Lira, Northern Uganda: a prospective cohort study.
Napyo A; Tumwine JK; Mukunya D; Waako P; Tylleskär T; Ndeezi G
Glob Health Action; 2020 Dec; 13(1):1833510. PubMed ID: 33121390
[TBL] [Abstract][Full Text] [Related]
14. Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
Rutherford GW; Horvath H
PLoS One; 2016; 11(10):e0162775. PubMed ID: 27736859
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anti-retroviral therapy treatment strategies in prevention of mother-to-child transmission in a teaching hospital in Ethiopia.
Kumela K; Amenu D; Chelkeba L
Pharm Pract (Granada); 2015; 13(2):539. PubMed ID: 26131041
[TBL] [Abstract][Full Text] [Related]
16. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
[TBL] [Abstract][Full Text] [Related]
17. Comparative Safety and Changes in Immunologic and Virologic Parameters of Dolutegravir versus Efavirenz-Based Antiretroviral Therapies Among HIV Patients: A Retrospective Cohort Study.
Ayal MA; Berha AB
HIV AIDS (Auckl); 2023; 15():173-190. PubMed ID: 37139483
[TBL] [Abstract][Full Text] [Related]
18. Mother-to-child transmission of HIV and its predictors among HIV-exposed infants at a PMTCT clinic in northwest Ethiopia.
Koye DN; Zeleke BM
BMC Public Health; 2013 Apr; 13():398. PubMed ID: 23621862
[TBL] [Abstract][Full Text] [Related]
19. Positivity rate, trend and associated risk factors of mother-to-child transmission of HIV among HIV-exposed infants.
Gutema G; Tola HH; Fikadu D; Leta D; Bejiga B; Tura JB; Abdella S; Mamo H
BMC Pediatr; 2023 Jun; 23(1):283. PubMed ID: 37280581
[TBL] [Abstract][Full Text] [Related]
20. Mother-to-child transmission of HIV infection and its associated factors in Ethiopia: a systematic review and meta-analysis.
Kassa GM
BMC Infect Dis; 2018 May; 18(1):216. PubMed ID: 29747581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
